SERVICES
Every engagement starts with a readiness diligence.
Six services, from investor readiness to fractional CFO and CMO roles. Each one lists what it covers and what you receive.
HOW AN ENGAGEMENT RUNS
- 01 Assess We start with a readiness diligence: the review your next investor will run, calibrated to the round being prepared.
- 02 Plan It ends in a remediation plan: what to fix, in what order, and who does it. The plan becomes the proposal.
- 03 Agree Each further service, from the data room to market and competitive analysis, is scoped and agreed on its own.
- 04 Run Ongoing roles run alongside your team and advisers: fractional CFO and fractional CMO monthly, in your systems, and board support ahead of each board meeting.
SERVICE 01 · THE ENTRY POINT
Readiness diligence
What will the next investor find, and what has to change first?
You receive: Assessment, ranked gaps, remediation plan
Founders also call it a mock due diligence or an investor readiness review.
Readiness diligence covers what your next investor will review
- Science Development state of the lead programme and the pipeline.
- Clinical and regulatory The path to the next milestone.
- Intellectual property Ownership, licences, filings, freedom-to-operate questions.
- Corporate Entity, governance, cap table and material contracts.
- Financials Plan, budget, use of funds and runway.
- Calibration Every area judged at the bar of the round being prepared.
The readiness diligence delivers three documents
- Readiness assessment Scored by area, with the gaps ranked by their effect on the round.
- Document request list The documents that are missing, listed for the company to supply.
- Remediation plan What to fix, in what order, and who does it.
SERVICE 02
Data room
Can every diligence request be answered from a document?
You receive: Data room, readiness score, open items
A data room built to answer before they ask
- Structure Set up against a sell-side readiness checklist.
- Open items Tracked as documents arrive, with a dated readiness memo at each review.
- Development section Scored on its own, against what an R&D diligence asks for.
SERVICE 03
Market and competitive analysis
How large is the opportunity, and who else is going after it?
You receive: Sourced report with scenarios
The deliverable is a written report with its sources cited.
- Market sizing Built bottom-up from its drivers, with every assumption stated.
- Competitor landscape A capability comparison across the programmes that matter.
- Scenarios Each scenario carries a stated probability.
- Regulatory research The rules and pathways the plan relies on: Swiss, EU, EMA and FDA.
SERVICE 04
Fractional CFO
Is the money buying milestones?
You receive: Financial model and its outputs, monthly close and reporting
Fractional CFO: one financial model, everything drawn from it
One model, so the budget, the forecast and the round size always agree.
- 01 Financial model Driver-based, built from the development plan, refreshed with actuals each period. The other five all come from it.
- 02 Use of funds The model's spend, mapped to the milestone each line pays for.
- 03 Scenarios The model run as base, delay and downside cases, with the cash low point and decision dates.
- 04 Cash forecast The model's next 13 weeks, week by week, when cash is tight.
- 05 Round analysis Round size set by the model's cash need to the next milestone, with dilution and valuation across rounds.
- 06 Grant applications The budget section of grant applications, in the funder's format, taken from the model.
Fractional CFO: we run the monthly cycle around the model
Actuals go into the model each month, so every report is measured against the plan investors were shown.
- 01 Financial model We refresh it with the month's actuals.
- 02 Accounting We run the monthly close where there is no finance function. Otherwise we work from the company's books, alongside its finance lead.
- 03 Reporting Management reporting each month: KPIs, variance against the model, burn and runway. Investor reporting once the round has closed.
SERVICE 05
Fractional CMO
Will the development plan carry the company to its next milestone?
You receive: A CMO on your team, the development plan and its outputs
Fractional CMO: one development plan, everything drawn from it
One plan, so the trials, the regulatory filings and the diligence answers tell the same story.
- 01 Clinical development plan Starts from the clinical strategy: indication, target population and the path to first clinical results. Then next studies, endpoints and go/no-go decisions, updated as data emerge. The other five all work from it.
- 02 Regulatory pathway The route to the next milestone, Swiss, EU, EMA or FDA, with its calendar.
- 03 Clinical oversight Trials supervised with internal teams and vendors: enrolment, data quality, interpretation of results.
- 04 Safety governance Benefit-risk followed as the programme runs, with safety counts reported each month.
- 05 Monthly medical status Programme, vendors, safety, regulatory calendar and risks, signed off by the CMO.
- 06 Clinical diligence package The development section of the data room, scored against what an R&D diligence asks.
SERVICE 06
Board support
Does the board have what it needs to decide?
You receive: Board packs, decision points, a board seat
Board support: the cash and the programme in one pack
The board sees the programme and the cash together, from the same model and the same plan.
- Board packs Prepared ahead of each meeting, with the finance from the model and the programme status from the development plan.
- Decision points Each go/no-go decision set out with its effect on cash and runway, so the board decides with both in view.
- Board seat A board or observer seat for one of us, where the company and LSI agree on it.